Media

Discover more about the psychedelic industry and Entheon’s pathway by watching and reading our talks, presentations and interviews.

Articles & Podcasts

Healthing
November 24, 2021

Biomedical company seeks to unlock the potential of psychedelics for mental health treatment

Read Now
INSIDER
November 23, 2021

5 genes that may affect your reaction to psychedelic drugs like 'magic' mushrooms and LSD

Read Now
InvestorsObserver
November 17, 2021

Do Traders Think Entheon Biomedical Corp (ENTBF) Can Keep Climbing Wednesday?

Read Now
Psych Congress Network
August 12, 2021

DMT Offers Alternative for Treating Substance Use Disorders

Read Now
The Psychedelic Therapy Podcast
October 22, 2021

The Psychedelic Therapy Podcast: "Genetic Testing for the Psychedelics Experience

Read Now
Canada's Podcast
October 15, 2021

Psychedelics and the future of treating substance abuse with John Lem and Timothy Ko

Read Now

Videos

Daily Mushroom + Entheon Biomedical Mental Health Town Hall
The Dales Report - Unlocking The Potential Of DMT
Benzinga Global Small Cap Conference- December 2021
Benzinga Healthcare Small Cap Conference - September 2021

Speak with Investor Relations

Please enter your information to receive our investor package or reach out to us directly using the information below.

Joseph Cullen
Investor Relations

ir@entheonbiomedical.com
+1 (778) 919-8615

Please remember our office hours are in Pacific Time (GMT-8, Vancouver - BC, Canada)
By submitting this form you agree to receive communications from Entheon Biomedical. We commit to never selling your data and to keep your information safe. Read our Privacy Policy.
Thank you!
We will contact you soon.
Oops! Something went wrong while submitting the form.